Health Care : Current Reviews

Intellectual property and regulatory challenges of microbiome inventions: Recent trends and solutions

Joint Event on International Conference on Applied Microbiology and Microbial Biotechnology & International Conference on Microbiome R&D and Biostimulants & 3^rd International Conference on Internal Medicine & Hospital Medicine

October 15-16, 2018 Ottawa, Canada

Kamala Janiyani

UC San Diego Extension, USA

Posters & Accepted Abstracts: Health Care Current Reviews

Abstract:

Statement of the Problem: In recent years, the use of Microbiome and their metabolites for clinical diagnostics and as therapeutics has gained increased attention as modes of treatment for various disorders. This has led to many start-up companies conducting clinical trials for various chronic diseases; as diverse as IBD and liver diseases. In spite of vast progress in this field, one of the major concerns for researchers is securing the Intellectual property rights (mainly patents) on Microbiome inventions (Bacteria, Viruses, and Fungi) that are categorized as naturally occurring products and therefore come under the Judicial exception of 35 U.S.C 101. In the present talk, I will discuss a few patents which have been successfully granted and are commercialized. Additionally, this talk will also cover the regulatory challenges associated with the use of live microbiome as biotherapeutics with recent trends and solutions.

Biography :

E-mail: janiyanik@gmail.com